Docs

Jameel Clinic at MIT and King Faisal Specialist Hospital and Research Centre launch pioneering AI early breast cancer detection tool in Saudi Arabia

ع
Jameel Clinic at MIT and King Faisal Specialist Hospital and Research Centre launch pioneering AI early breast cancer detection tool in Saudi Arabia
9 November 2023
Saudi Arabia

The Jameel Clinic, the epicentre of artificial intelligence (AI) in healthcare at the Massachusetts Institute of Technology (MIT), and the King Faisal Specialist Hospital and Research Centre (KFSH&RC) have joined forces to roll out Mirai, a pioneering AI tool that can predict breast cancer up to five years earlier, and more accurately, than current mainstream screening techniques.

Introducing the tool for the first time in Saudi Arabia, the partnership between the MIT Jameel Clinic and KFSH&RC aims to deploy AI-enabled health technologies to help save lives and to revolutionise the landscape of healthcare in the country, especially in breast cancer care, for which the chances of treatment can double with early detection.

The Jameel Clinic, co-founded by MIT and Community Jameel in 2018, is collaborating with KFSH&RC to deploy other innovative AI tools, including for the prediction of lung cancer. These tools are undergoing tests on a wide range of patients, under the supervision of specialist doctors, to ensure that systematic health results are produced in a scientifically accurate manner.

A non-invasive, deep-learning algorithm that can predict breast cancer using only a patient’s mammogram, Mirai is equally effective across different races and ethnicities, which presents a major advance for health equity.

Mirai was trained on a dataset of over 200,000 exams from Massachusetts General Hospital (MGH), and was validated on test sets from MGH, the Karolinska Institute in Sweden, and Chang Gung Memorial Hospital in Taiwan. Mirai is now installed at MGH and the team’s collaborators are actively working on integrating the model into clinical care.

In July 2023, the MIT Jameel Clinic and KFSH&RC announced a partnership aimed at advancing clinical AI research. The partnership seeks to enhance patient care, improve clinical outcomes and reduce healthcare costs through the development and implementation of advanced AI tools and solutions.

Related

Regina Barzilay looks ahead at AI in cancer research and treatment in 2025

Jameel Clinic co-lead Jim Collins and collaborators awarded up to USD 27m by Advanced Research Projects Agency for Health for antimicrobial resistance platform

MIT Jameel Clinic breast cancer risk prediction model MIRAI is validated on more than 1.5 million mammograms in 43 hospitals in 14 countries

Regina Barzilay joins the Futurist Summit to discuss new frontiers of medicine and the MIT Jameel Clinic

MIT Jameel Clinic faculty co-lead Regina Barzilay features on the PBS Nova documentary 'AI revolution'

MIT Jameel Clinic principal investigator Vinod Vaikuntanathan honoured for exceptional teaching

New Cancer Grand Challenges global team MATCHMAKERS includes the MIT Jameel Clinic's Regina Barzilay

MIT Jameel Clinic's Sybil featured in Newsweek top-10 best hospitals in the world

MIT Jameel Clinic hosts first conference in Saudi Arabia to drive the use of artificial intelligence in healthcare

MIT Jameel Clinic will tomorrow host first conference in Saudi Arabia exploring the role of artificial intelligence in healthcare

Fadel Adib wins inaugural Great Arab Minds award for engineering and technology

MIT Jameel Clinic fellow Shrooq Alsenan appointed assistant professor at Princess Nourah University

MIT Jameel Clinic principal investigator Dina Katabi elected to National Academy of Sciences

MIT Jameel Clinic’s Regina Barzilay wins new $1 million prize for artificial intelligence

MIT Jameel Clinic faculty use deep learning to identify powerful new antibiotic

MIT Jameel Clinic tackling cancer, Alzheimer’s with funding for AI technologies that aim to detect and prevent diseases

Regina Barzilay, James Collins, and Phil Sharp to lead the MIT Jameel Clinic

We use cookies on our site.